The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum

British Journal of Dermatology

Volumn 154, Issue 2, 2006, Pages 319-324

  Caproni, M ^a   Torchia, D ^a   Schincaglia, E ^a   Volpi, W ^a   Frezzolini, A ^b   Schena, D ^c   Marzano, A ^d   Quaglino, P ^e   De Simone, C ^f   Parodi, A ^g   Barletta, E ^a   Fabbri, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

Author keywords

CD40 CD40L system; Erythema multiforme; Fas FasL system; Stevens Johnson syndrome; T lymphocytes; Toxic epidermal necrolysis

Indexed keywords

ALKALINE PHOSPHATASE; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CD68 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; MYELOPEROXIDASE; T6 ANTIGEN;

ADULT; ARTICLE; BIOPSY; CELL INFILTRATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHEMA MULTIFORME; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; EPIDERMAL NECROLYSIS, TOXIC; ERYTHEMA MULTIFORME; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; SKIN; STEVENS-JOHNSON SYNDROME;

EID: 33644878873     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.07023.x     Document Type: Article

References (36)

1. Bastuji-Garin S Rzany B Stern RS et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme Arch Dermatol 1993 129 92 6
2. Assier H Bastuji-Garin S Revuz J et al. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes Arch Dermatol 1995 131 539 43
3. Roujeau JC Kelly JP Naldi L et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis N Engl J Med 1995 333 1600 7
4. Khalil I Lepage V Douay C et al. HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme J Invest Dermatol 1991 97 697 700
5. Aurelian L Ono F Burnett J Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component Dermatol Online J 2003 9 1
6. Stampien TM Schwartz RA Erythema multiforme Am Fam Physician 1992 46 1171 6
7. No authors listed. Cutaneous reactions to analgesic-antipyretics and non-steroidal anti-inflammatory drugs. Analysis of reports to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologia Dermatology 1993 186 164 9
8. Malmström M Ruokonen H Konttinen Y et al. Herpes simplex virus antigens and inflammatory cells in oral lesions in recurrent erythema multiforme Acta Derm Venereol (Stockh) 1990 70 405 10
9. Kokuba H Imafuku S Huang S et al. Erythema multiforme lesions are associated with expression of a herpes simplex virus (HSV) gene and qualitative alterations in the HSV-specific T-cell response Br J Dermatol 1998 138 952 64
10. Kokuba H Aurelian L Burnett J Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-γ is expressed in HAEM lesions and tumor necrosis factor-α; in drug-induced erythema multiforme lesions J Invest Dermatol 1999 113 808 15
11. Inachi S Mizutani H Shimizu M et al. Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome Arch Dermatol 1997 133 845 9
12. Pichler WJ Deciphering the immune pathomechanism of cutaneous drug reactions Allergy 2002 57 34 6
13. Nassif A Bensussan A Dorothee G et al. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis J Invest Dermatol 2002 118 728 33
14. Paquet P Piérard GE Soluble fractions of tumor necrosis factor-alpha, interleukin-6 and of their receptors in toxic epidermal necrolysis: a comparison with second-degree burns Int J Mol Med 1998 1 459 62
15. Posadas SJ Padial A Torres MJ et al. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity J Allergy Clin Immunol 2002 109 155 61
16. Yawalkar N Egli F Hari Y et al. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions Clin Exp Allergy 2000 30 847 55
17. Ito K Hara H Okada T et al. Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistochemical study of Fas and Fas-ligand expression Clin Exp Dermatol 2004 9 679 80
18. Nassif A Moslehi H Le Gouvello S et al. Evaluation of the potential role of cytokines in toxic epidermal necrolysis J Invest Dermatol 2004 123 850 5
19. Abe R Shimizu T Shibaki A et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand Am J Pathol 2003 162 1515 20
20. Paul C Wolkenstein P Adle H et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis Br J Dermatol 1996 134 710 14
21. Viard I Wehrli P Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 1998 282 490 3
22. Schonbeck U Libby P The CD40/CD154 receptor/ligand dyad Cell Mol Life Sci 2001 58 4 43
23. Caproni M Volpi W Macchia D et al. Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test Exp Dermatol 2003 12 621 8
24. Spandau U Brocker EB Kampgen E et al. CC and CXC chemokines are differentially expressed in erythema multiforme in vivo Arch Dermatol 2002 138 1027 33
25. Paquet P Quatresooz P Piérard GE Factor-XIIIa-positive dendrocytes in drug-induced toxic epidermal necrolysis (Lyell's syndrome): paradoxical activation in skin and rarefaction in lymph nodes Dermatology 2003 206 374 8
26. Paquet P Nikkels A Arrese JE et al. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis Arch Dermatol 1994 130 605 8
27. Zaim MT Giorno RC Golitz LE et al. An immunopathological study of herpes-associated erythema multiforme J Cutan Pathol 1987 14 257 62
28. Villada G Roujeau JC Clerici T et al. Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases Arch Dermatol 1992 128 50 3
29. Nassif A Bensussan A Boumsell L et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells J Allergy Clin Immunol 2004 114 1209 15
30. Paquet P Piérard GE Erythema multiforme and toxic epidermal necrolysis: a comparative study Am J Dermatopathol 1997 19 127 32
31. Paquet P Piérard GE Differential pathomechanisms of epidermal necrolytic blistering diseases Int J Mol Med 2002 10 695 9
32. Correia O Delgado L Barbosa IL et al. Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis J Am Acad Dermatol 2002 47 58 62
33. Chrysomali E Lozada-Nur F Dekker NP et al. Apoptosis in oral erythema multiforme Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 83 272 80
34. Sayama K Yonehara S Watanabe Y et al. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes J Invest Dermatol 1994 103 330 4
35. Muerkoster S Laman JD Rocha M et al. Functional and in situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity Clin Cancer Res 2000 6 1988 96
36. Lerner LH Qureshi AA Reddy BV et al. Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome J Invest Dermatol 2000 114 196 9